Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers

被引:105
|
作者
Carcangiu, ML
Radice, P
Manoukian, S
Spatti, G
Gobbo, M
Pensotti, V
Crucianelli, R
Pasini, B
机构
[1] Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Dept Prevent & Predict Med, I-20133 Milan, Italy
[4] Ist Nazl Tumori, Gynecol Unit, I-20133 Milan, Italy
[5] FIRC, Inst Mol Oncol, Milan, Italy
关键词
BRCA1; prophylactic salpingo-oophorectomy; fallopian tube; atypical hyperplasia; carcinoma in situ;
D O I
10.1097/01.pgp.0000101082.35393.84
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although growing numbers of tubal carcinomas in carriers of BRCA1 and BRCA2 germline mutations have been reported, very little is known about the nature and frequency of their possible precursor lesions. The aim of this study is to investigate the occurrence of atypical proliferative tubal lesions in grossly normal fallopian tubes from 26 women with BRCA1 and BRCA2 germline mutations who underwent prophylactic salpingo-ooophorectomy and whose ovaries were histologically negative for carcinoma. Fallopian tubes from 49 women who had undergone hysterectomy with salpingo-oophorectomy for uterine leiomyoma served as controls. In the 22 BRCA1-mutated women, there were two in situ carcinomas and two atypical hyperplasias of the tubal epithelium. The tubes of the BRCA2-mutated women and of the 49 control women did not show any atypical proliferation. The frequency of proliferative lesions of the tubal epithelium, including in situ carcinoma, appears to be increased in BRCA1 mutation carriers. Removal and thorough examination of the fallopian tubes at the time of surgical prophylaxis for ovarian cancer is therefore recommended.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 50 条
  • [41] Barriers to hormone replacement therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
    DiSilvestro, J. B.
    Haddad, J.
    Robison, K. M.
    Beffa, L. B.
    Laprise, J.
    Wilbur, J. Scalia
    Raker, C.
    Hofstatter, E.
    Dalela, D.
    Brown, A. K.
    Bradford, L.
    Toland, M.
    Stuckey, A. R.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 260 - 260
  • [42] Incidental diagnosis of primary fallopian tube carcinoma during prophylactic salpingo-oophorectomy in BRCA2 mutation carrier
    Peyton-Jones, B
    Olaitan, A
    Murdoch, JB
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (12) : 1413 - 1414
  • [43] Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene
    Finch, A.
    Metcalfe, K.
    Lui, J.
    Springate, C.
    Demsky, R.
    Armel, S.
    Rosen, B.
    Murphy, J.
    Elit, L.
    Sun, P.
    Narod, S.
    CLINICAL GENETICS, 2009, 75 (03) : 220 - 224
  • [44] Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
    Powell, C. B.
    Swisher, E. M.
    Cass, I.
    McLennan, J.
    Norquist, B.
    Garcia, R. L.
    Lester, J.
    Karlan, B. Y.
    Chen, L.
    GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 364 - 371
  • [45] Ovarian Stroma and Adenofibroma in Fallopian Tubes of Women Undergoing BRCA Prophylactic Salpingo-Oophorectomy
    Walts, A. E.
    Cass, I.
    Barbuto, D.
    LABORATORY INVESTIGATION, 2009, 89 : 240A - 240A
  • [46] Ovarian Stroma and Adenofibroma in Fallopian Tubes of Women Undergoing BRCA Prophylactic Salpingo-Oophorectomy
    Walts, A. E.
    Cass, I.
    Barbuto, D.
    MODERN PATHOLOGY, 2009, 22 : 240A - 240A
  • [47] Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
    Garcia, Christine
    Lyon, Liisa
    Conell, Carol
    Littell, Ramey D.
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 723 - 726
  • [48] Quality of life in BRCA1 and BRCA2 mutation carriers (B1/2) following risk-reducing salpingo-oophorectomy (RRSO).
    Domchek, Susan M.
    Li, Jiaqi
    Digiovanni, Laura
    Voong, Chan
    Mueller, Rebecca
    Johnson, Lauren
    Epperson, C. Neill
    Friedman, Sue
    Gracia, Clarisa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Estrogens and Cognition in BRCA1/2 Mutation Carriers Following Prophylactic Salpingo-Oophorectomy (Oct, pg 522, 2010)
    Schwartz, Deborah
    Finch, Amy
    Tierney, Mary
    Hampson, Elizabeth
    Narod, Steven
    Einstein, Gillian
    GENDER MEDICINE, 2011, 8 (01) : 56 - 56
  • [50] Timing and acceptance of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers enrolled in an integrated community-based health care system
    Kwan, Karen W.
    Morton, Stephanie W.
    Chung, Joanie
    CANCER RESEARCH, 2022, 82 (04)